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transmit proliferative signals in wild or chimeric receptor con- Abstract To investigate the functional domains for signal 
transduction of human Mpl, we constructed a series of human structs. Moreover, Mpl mediates the differentiation signals, 
c-mpl cDNAs with various deletions in the cytoplasmic domain, including those for the induction of megakaryocyte lineage- 
and then introduced each eDNA into muriue IL-3-dependent specific transcriptional factors and cell surface antigens in 
myeloid leukemia FDCIP2 cells to establish stable transform- several hematopoietic cell lines. These results indicated that 
ants. We examined the growth and differentiation responses the cytoplasmic domain of the Mpl plays important roles in 
and tyrosine phosphorylation of the intracellular signaling mitogenic and differentiation signal transduction. It is thought 
proteins including Jak2, Tyk2, Stat3, Stat5, Vav, SHPTP2, that the Mpl mediates proliferation and differentiation signals 
Cbl, She and She-associated p145 when receptor stimulation through the phosphorylation of intracellular signaling pro- 
occurred after thrombopoietin (TPO) binding. TPO stimulated teins. We demonstrated that TPO induces the tyrosine phos- 
cell proliferation and induced the expression of megakaryocyte phorylation of several intracellular proteins including Janus 
lineage-specific AP-51 and CD61 cell surface antigens and 
tyrosine phosphorylation of the signaling proteins in transform- kinases (Jaks), Stats (signal transducers and activators of tran- 
ants expressing full length human Mpl. These results suggested scription) [17,18], and others [19-21]. To investigate the func- 
that Mpl not only induced proliferation but also transduced tional domains for signal transduction of the human Mpl, we 
megakaryocyte-specific differentiation signals into FDCIP2 have established FDC/P2 expressing a series of truncated hu- 
cells. Mutational analysis of human Mpl indicated that the N- man Mpl receptors in murine IL-3-dependent myeloid leuke- 
terminal region of its cytoplasmic domain is necessary and mic FDC/P2 cells and examined the tyrosine phosphorylation 
sufficient to transduce proliferation and differentiation signals of signaling proteins and the proliferative and differentiation 
into cells, while the C-terminal region may also play important responses by TPO stimulation in each transformant. In this 
roles in transducing the differentiation signals, report, we discuss the relationship between the tyrosine phos- 
Key words." Mpl; Thrombopoietin; Proliferation; phorylation of signaling proteins and cellular responses, in- 
Differentiation; Signal transduction cluding proliferation and differentiation. 
2. Materials and methods 
1. Introduction 2.1. Cytokines and antibodies 
Recombinant murine IL-3 from Escherichia coli and recombinant 
human TPO from Chinese hamster ovary (CHO) cells were provided 
The proto-oncogene c-mpl [1,2] is a member of the cytokine by the Production and Technology group of Kirin Brewery Co., Ltd. 
receptor superfamily, including the receptors for other hema- Rabbit anti-human Mpl polyclonal antibody was generated by immu- 
topoietic growth factors such as interleukins (ILs), colony- nizing rabbits with purified CHO-derived soluble human Mpl [6]. 
stimulation factors (CSFs) and growth hormone (GH). We Mouse anti-phosphotyrosine monoclonal antibody 4G10 was pur- 
and other groups identified c-mpl ligand, thrombopoietin chased from Upstate Biotechnology Inc. (Lake Placid, NY). Rabbit 
polyclonal antibodies including anti-Jak2, anti-Tyk2, anti-Star3, anti- 
(TPO), which regulates megakaryopoiesis and thrombopoiesis Stat5, anti-Vav, anti-SHPTP2, anti-Cbl and anti-Shc were from Santa 
[3-6]. Human Mpl consists of 635 amino acids, containing the Cruz Laboratories Inc. (Santa Cruz, CA). Goat anti-mouse or rabbit 
extracellular domain with two repeats of a characteristic do- Ig F(ab')2 conjugated horseradish peroxidase were from Amersham 
main structure that includes four conserved cysteine residues (Arlington Heights, IL). Anti-murine CD61 antibody was obtained 
from Pharrningen (San Diego, CA). Anti-murine megakaryocyte/ 
and a WSXWS motif, a single transmembrane domain and a platelet antigen antibody AP-51 [15] was provided by Dr. T. Nagasa- 
cytoplasmic domain with two structural motifs called boxl wa of Tsukuba University. Anti-rat or hamster antibody conjugated 
and box2. Like other members of the cytokine receptor super- with fluorescence isothiocyanate (FITC) was from Biosource Inter- 
family, Mpl does not contain kinase-related or nucleotide- national Inc. (Camarrilo, CA). 
binding consensus equences in its cytoplasmic domain, and 
2.2. Plasmid construction 
its intracellular signaling pathways have not yet been fully The humpl-Pasl2 plasmid [6] carrying a full length of the human p- 
elucidated, form c-mpl cDNA[2] was provided by Amgen Inc. (Thousand Oaks, 
Recent studies by several groups, including us, indicated CA). Truncated human c-mpl cDNAs were constructed as follows. 
that the activated Mpl induces cellular proliferation and dif- The 1.5 kb DNA fragment for the N-terminal region of human mpl 
was isolated by digestion of the humpl-Pasl2 with EcoRI and SacI 
ferentiation [7-16]. The cytoplasmic domain of the Mpl can restriction enzymes. The DNA fragments for various lengths of the C- 
terminal region of human mpl was generated by PCR, using a sense 
*Corresponding author. Fax: (81) (272) 52-2307. strand primer (5'-GGGGAGCTCGTGGTCGGACCCAACTAGG- 
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G-3') encoding the inner SacI site of c-mpl and each reverse primer Wild type Mp1522Mp1540Mp1558Mp1576Mp1594Mp1612Mp1635 
(5'-GGGACTAGTCCTGTAGTGTGCAGGAAACTG-3', Mp1522; 25 
5'-GGGACTAGTATCTGAGACTGTGGCCTTGGG-3', Mp1558; ~, 
5'-GGGACTAGTCTCTGAGGACTTGGGGAGGAT-3', Mp1576; 
5'-GGGACTAGTCAATCTTCGGTAGTCCATCTG- 3', Mp1594; | 
5'-GGGACTAGTCTCAGCCATGGGTGGGCACAC-3', Mp1612; 
5'-GGGACTAGTAGGCTGCTGCCAATAGCTTAG- 3', Mp1635) ~1 • • • • • • 
o containing an SpeI site. These were digested with the restriction en- ] Y521 
zymes SacI and SpeI. The N- and C-terminal DNA fragments were box1 o 
ligated and inserted into the EcoRI and Spel sites downstream of the 54! I~ J ~- 
promoter/enhancer sequence in the mammalian expression vector . Y542 
pSMT201 (Ohashi et al., unpublished) containing the influenza virus box2 . ~! 
hemagglutinin (HA) tag [22] and hexahistidine tag sequences and stop ! 
(516) 5 codon downstream of the SpeI site. 4 Y591 
(534) 5 
Y626 2.3. Cells and transfection (552) 5 Y631 
IL-3-dependent mouse myeloid leukemia cell line FDC/P2 cells [23] [ (570) 6 ~I-tA His6 Tag 
were maintained in Iscove's modified Dulbecco's medium (IMDM) 635 (588) 635 
(Gibco/BRL, Gaithersburg, MD) containing 10% fetal calf serum (611) (611) 
(FCS) and 1 ng/ml IL-3. The plasmid was transformed into cells as 
described [24,25]. Briefly, pSMT201 plasmids carrying various lengths Fig. 1. Schematic representation of truncated c-Mpl. A viral HA 
of truncated c-mpl cDNA were transfected into FDC/P2 cells with the epitope and hexahistidine tags were introduced into the C-teminal 
pMCneo plasmid [26] by electroporation, then selected in IMDM region of the receptors (indicated by diamonds). Boxes 1 and 2 are 
containing 10% FCS, 1 ng/ml IL-3 and 0.5 mg/ml G418. Selected indicated by hatched and open boxes, respectively. Tyrosine residues 
transformants were cloned by limiting dilution, in the cytoplasmic domain (Y521, Y542, Y591, Y626, Y631) are in- 
dicated by the thick line. 
2.4. Cell proliferation assay 
Cell proliferation was measured by means of an MTS colorimetric 
assay (Promega, Madison, WI) [27] based on the activity of dehydro- 
genase enzyme in metabolically active cells. Exponentially growing signal transduction, we constructed a series of human c-mpl 
cells were washed three times with IMDM containing 10% FCS, cDNAs with various deletions in their cytoplasmic domains. 
then resuspended with IMDM containing 10% FCS at a density of Fig. 1 shows a schematic representation of the human Mpl 
2.5 x 104 cells/ml. Cell suspension (100 ktl) was seeded into each well of mutants. The cDNAs included the full length human c-mpl 
96-well tissue culture plates. Various concentrations of TPO (100 p.1) cDNA (mp1635) and six mutants (mp1612, mp1594, mp1576, 
diluted with IMDM medium containing 10% FCS were added into 
each well. The plates were then incubated in a CO2 incubator for 72 h mp1558, mp1540, and mp1522) in which the cytoplasmic do- 
at 37°C. Thereafter, 20 ~tl of MTS/PMS was added into each well and main was deleted from the C-terminal end up to amino acid 
the plates were further incubated for 4 h at 37°C. Cell growth was positions 613, 595, 559, 577, 541 and 523, respectively. These 
determined by measuring the absorbance at 492 nm. cDNAs also contained the sequence ncoding the viral HA 
2.5. Immunoprecipitation andimmunoblotting epitope and hexahistidine tags in their C-termini recognized 
Immunoprecipitation and immunoblotting analysis were performed by the mouse monoclonal antibody 12CA5 [22] or nickel che- 
as described [25]. Briefly, 2X 107 cells starved for 10 h in IMDM late gels. FDC/P2 cells were transformed with expression plas- 
containing 10% FCS were incubated in the absence or presence of mids carrying the mutant cDNA as described above. Stable 
5 ng/ml TPO for 15 min at 37°C, then solubilized with lysis buffer: transformants expressing each mutant were isolated and de- 
20 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1% NP40, 150 mM NaC1, 
10% glycerol, 1 mM sodium orthovanadate, and complete protease signated FDCP-MpI635, FDCP-Mpl612, FDCP-Mp1594, 
inhibitor cocktail (Boehringer Mannheim, Mannheim, Germany). FDCP-Mp1576, FDCP-Mp1558, FDCP-Mp1540 and FDCP- 
Clear cell lysates were immunoprecipitated with the desired polyclonal Mp1522. Expression of the mutant Mpl in these transformants 
antibody and protein G Sepharose FF gels (Pharmacia Biotech, Upp- was first analyzed by immunoprecipitation a d immunoblot- 
sala, Sweden) for 2 h at 4°C. After centrifugation, the precipitates 
were subjected to 7.5% SDS-PAGE and then immunoblotted with ting using the 12CA5 monoclonal antibody. As shown in Fig. 
anti-HA antibody 12CA5 or anti-phosphotyrosine monoclonal anti- 2, each transformant expressed mature Mpl receptor with 
body (4G10). After extensive washing, the blots were visualized with molecular weights predicted from the size of the deletion. 
an ECL immunoblotting detection system (Amersham) according to The bands with a lower molecular weight seen in all trans- 
the manufacturer's instructions, formants are likely to be immature Mpl, because they were 
2.6. Flow cytometry not tyrosine phosphorylated after TPO stimulation (Fig. 3A). 
The cell surface expression of the hematopoietic cell surface anti- Parental FDC/P2 cells have no c-mpl transcript and did not 
gens in IL-3- or TPO-stimulated cells was analyzed using flow cy- express the murine Mpl receptor on the cell surface. We con- 
tometry. Cells were cultured with IL-3 or TPO (1 X 10 ~ cells) were firmed the endogenous expression of the murine Mpl on es- 
washed, then resuspended in phosphate buffered saline (PBS) contain- 
tablished transformants by means of reverse-transcriptional ing 5% FCS and 0.1% NaN3. They were incubated for 30 min at 4°C 
with first antibody in a final volume of 0.1 ml, followed by FITC- PCR using murine c-mpl-specific primers. The murine c-mpl 
conjugated second antibody for 30 min at 4°C. All measurements transcript was undetectable in all transformants (data not 
were performed using a FACScan flow cytometer (Becton Dickinson, shown). These results indicated that all mutants of the human 
San Jose, CA). Mpl were expressed in the transformants. 
3. Results 3.2. Tyrosine phosphorylation of cellular signaling proteins 
mediated by the truncated human Mpl receptors 
3.1. Generation ofFDCIP2 transformants expressing truncated In the cytokine receptor system, several cellular proteins are 
human Mpl tyrosine-phosphorylated after ligand binding to the receptor 
To determine the functional domains of the human Mpl for and involved in intracellular signal transduction. We demon- 
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,~q, ~ ¢,,~b ^¢o ¢~, ,xq, ~¢o tated with Shc in FDCP-MpI635, FDCP-Mpl612, FDCP- 
--~J --~ ~J ~J ~J --~ ~ Mp1594 and FDCP-MpI576 cells (Fig. 3J). 
123 ~ ,~,'~ @'~ ,~ x.~ ~'~ ~'~ ~'~ 
3.3. Mpl-mediated cell proliferation requires the 45 membrane- 
IP : anti-Mpl proximal amino acids of  human Mpl 
85 WB" anti-12CA5 To determine the Mpl cytoplasmic region required for cell 
proliferation, we examined the TPO-dependent growth of the 
transformants. As shown in Fig. 4, FDCP-MpI635, FDCP- 
Mp1612, FDCP-MpI594, FDCP-Mp1576 and FDCP-Mp1558 
cells proliferated in response to TPO in a dose-dependent 
Fig. 2. Mpl receptor expression in the FDC/P2 transformants. Cell 
lysates of each transformant were prepared as described in Section manner. FDCP-Mp1558 cells had a lower growth response 
2. Mpl proteins were immunoprecipitated (IP) with anti-human Mpl than the other transformants. However, FDCP-Mp1540, 
polyclonal antibody, separated on 7.5% SDS-PAGE, and then aria- FDCP-Mp1522 and parental FDC/P2 cells did not proliferate 
lyzed by immunoblotting with 12CA5 mouse monoclonal antibody in response to TPO even at very high concentrations. These 
(WB). The mobilities of prestained molecular markers are shown on results indicated that the membrane proximal region in Mpl the left of the panel. Lanes 1-7 indicates FDCP-Mp1522, FDCP- 
Mp1540, FDCP-MpI558, FDCP-Mp1576, FDCP-Mp1594, FDCP- cytoplasmic domain is required for cell proliferation and that 
Mp1612, and FDCP-MpI635, respectively, it is involved in Mpl-mediated growth signal transduction. As 
described above, tyrosine-phosphorylation of Jak2, Tyk2 and 
Vav required the 45 amino acids of Mpl proximal to the 
plasma membrane (Fig. 3B-D). Moreover, the tyrosine phos- 
strated that TPO induced the tyrosine phosphorylation of phorylation levels of these proteins in FDCP-Mp1558 cells 
Jak2 and Tyk2, Stat3 and Stat5 in FDCP-hMpl5 cells engi- were low. These results indicate that the cytoplasmic domain 
neered to express full-length uman Mpl [14]. Other proteins, of the Mpl required for cell proliferation corresponds to that 
including Cbl, Vav, SHPTP2, She, She-associated p145 and for the tyrosine-phosphorylation of these signaling proteins. 
Mpl itself are also tyrosine-phosphorylated by TPO in our 
and other cell systems [8,9,11-14,28]. To investigate the Mpl 
functional domains for phosphorylation of the cellular pro- 5221540 558 576 594 612 635 mutant Mpl 
teins, we examined the TPO-induced tyrosine phosphorylation - + I /+-  - + - + - + - + - + TPO stimulation 
of these proteins by TPO stimulation in transformants. 
Starved cells were stimulated or not with TPO, lysed, immu- " 
noprecipitated with the indicated antibody, resolved by SDS- A . . . . . .  ~ ~ IP:anti-Mpt 
PAGE and immunoblotted using an anti-phosphotyrosine 
4G10 antibody. Fig. 3 shows the tyrosine phosphorylation 
of signaling proteins in Mpl deletion mutants. Mpl itself, B IP:anti-Jak2 
Jak2 and Tyk2 were tyrosine-phosphorylated by TPO stimu- 
lation in EDCP-Mp1635, FDCP-Mp1612, FDCP-Mp1594, 1 ........ ~ .... , ,~,~,~.  ~,~] IP:anti-Tyk2 
EDCP-Mp1576 and FDCP-MpI558 cells, but not in unstimu- 
luted cells (Fig. 3A-C). The phosphorylation level of these O - ~, ~:: "~ '~:~ '~ " IP:anti-Vav 
proteins in FDCP-Mp1558 cells was relatively low. These pro- I 
teins were not tyrosine-phosphorylated in FDCP-Mp1540 and [ E ~i~ '~ ~ 
FDCP-MpI522 cells. Although Vav was weakly tyrosine-phos- "~ .~' ~ ~,~l  IP:anti-Stat3 
I phorylated before TPO stimulation, it was obviously phos- phorylated thereafter. The phosphorylation spectrum of Vav I I  '~ ~ m I I P:anti-Stat5 in transformants was the same as that of Mpl, Jak2 or Tyk2 
(Fig. 3D). These results demonstrated that the phosphoryla- ] - ~  G ~ ~ ,~ . . . .  IP:anti-Cbl 
tion of Mpl, Jak2, Tyk2 and Vav after TPO stimulation re- 
quired the membrane proximal region of the human Mpl, 
which contains the boxl region conserved in other members H IP:anti-SHPTP2 
of the cytokine receptor superfamily. On the contrary, tyro- 
sine phosphorylation of the Stat3, Stath, Cbl and SHPTP2 ][ ~1~ ~ ~ ................... ~[ - .  
required the membrane proximal domain containing 18 I o ~ ~ ~ ~ ~i ! 
more distal amino acids (amino acid positions 512-576). - . . . . . . . . . . . .  IP:anti-Shc 
TPO induced the tyrosine-phosphorylation of these proteins 
in FDCP-Mp1635, FDCP-Mpl612, FDCP-Mp1594 and J 
FDCP-Mp1576 cells, but not in FDCP-Mp1558, FDCP- 
Mp1540 and FDCP-Mp1522 cells (Fig. 3E-H). On the other Fig. 3. Tyrosine phosphorylation f Mpl (A), Jak2 (B), Tyk2 (C), 
hand, phosphorylation of the She required the most distal Vav (D), STAT3 (E), STAT5 (F), Cbl (G), SH-PTP2 (H), She (I) 
region of the Mpl receptor (Fig. 31). Only full-length and She-associated p145 (J) in FDC/P2 cells expressing various Mpl 
Mp1635 (FDCP-Mp1635) mediated full tyrosine phosphoryla- mutants. Starved cells were incubated in the absence ( ) or pres- 
ence (+) of TPO for 15 min. The cells were lysed and then immuno- 
tion of the She. She was very weakly tyrosine-phosphorylated precipitated with an indicated polyclonal antibody. Immunoprecipi- 
in FDCP-Mpl612 and FDCP-MpI594 cells• However, tyro- tates were separated on 7.5% SDS-PAGE and then analyzed by 
sine-phosphorylated She-associated p145 co-immunoprecipi- immunoblotting with anti-phosphotyrosine a tibody 4G10. 
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Moreover, these results uggested that these signaling proteins AP-51 CD61 
are involved in the Mpl-mediated signal transduction path- 
ways for cell proliferation. A 
FDCP-Mp1522 
3.4. Megakaryocyte lineage-specific differentiation signals h~ ~ 
mediated by the truncated human Mpls lj" ~__ ___ 
TPO induces expression of megakaryocyte-specific tran- 
scriptional factors and cell surface antigens on some hemato- A h FDCP-Mp1540 
poietic cell lines including CMK [29], UT7 [30] and FD-TPO J \  [15], which endogenously or exogenously express Mpl recep- 
tor. In FDCP-hMpl5 cells [14], TPO increased the expression - - -  
of megakaryocyte/platelet-specific c ll surface antigens AP-51 i 
and CDdl (data not shown). To determine the Mpl cytoplas- /~\ |  FDCP-Mp1558 
mic regions functional for cellular maturation signals, we ex- 
amined the capacity of mutant Mpl receptors to increase the .D 
expression of megakaryocyte-specific antigens AP-51 and E= 
CDdl upon TPO stimulation. All transformants except = A . h  
FDCP-Mp1522 and FDCP-Mp1540 were cultured in the pres- ~ o ~ ~_~ FDCP-Mp1576 
ence of IL-3 or TPO and the expression of cell surface anti- >~ 
gens was analyzed by means of flow cytometry. FDCP- 
Mp1522 and FDCP-MpI540 cells were grown in medium con- w ~ ] ~  
taining IL3, or IL3 and TPO because these cells lack a pro- t ~  J ~  FDCP-Mp1594 
liferative response to TPO. As shown in Fig. 5, the expression Jk of both AP-51 and CDdl antigens on FDCP-MpI635, FDCP- 
Mp1576, FDCP-Mp1558 cells was enhanced by TPO. In con- 
trast, there were no changes in expression levels of AP-51 and ~ 
CDdl in FDCP-Mpldl2, FDCP-Mp1594, FDCP-MpI540 and J~ lL  J~k  FDCP-Mp1612 
FDCP-MpI522 cells in the presence of TPO. No changes in 
expression of these antigens were induced even after 1 month 
of culture in medium containing TPO. Furthermore, in other A 
FDC/P2 transformants ransfected with mpldl2 or mp1594 ~ !  A 
cDNA, the expression of cell surface antigens was not en- ~ ~ k  FDGP-Mp1635 
hanced in response to TPO. These results indicated that the 
C-terminal (an 595-634) and membrane-proximal regions (an i f 
512-558) of the Mpl cytoplasmic domain play important roles 100 t 01 102 103 104100 t01 t 02 103 104 
for cellular differentiation signaling, including the inducible 
expression of megakaryocyte-specific cell surface antigens. Fluorescence intensity 
Fig. 5. Flow cytometry of megakaryocyte/platelet-specific cell sur- 
face antigens, AP-51 (left panels) and CDdl (right panels) in trans- 
1.1 ~ parent ~ formants timulated by IL-3 or TPO. Cells cultured with IL-3 (thin 
I Mpl522 ~ line) or TPO (thick line) were incubated for 30 min at 4°C with 
anti-AP-51 or anti-CDdl antibody. After washing, the cells were 
1 X Mp1540 / then stained for 30 min with FITC-conjugated second antibody. 
~ Mpl558 ~ Fluorescence intensity was determined using a FACScan flow cyto- 
meter. 
O 
0.9 + Mpl594 , / ' I  / I . J  The results also indicated that the cytoplasmic domain of hu- 
.~. ~ ~E~ ~ man Mpl receptor for cell differentiation signals is identical to 
0 that for cell proliferative signals. As described above, intracel- 
~0.8  _ - ~  / /~, ,~ A/ activationlUlar signalingafterPrOteins were tyrosine-phosphorylatedthere corr la-bY Mpl 
TPO binding. However, was no 
.o ~ y / /  tion between the tyrosine phosphorylation of signaling pro- 
< 0.7 teins and the induction of megakaryocyte-specific ell surface 
antigen expression in each transformant. These findings sug- 
a_ _,. ~ gested that these differentiation signals are mediated by other 
0.6 --,-- ,  ,,,,;,i "', r,,,,,u , , ,-, ,n , ... . . . .  signal transduction pathways through unknown signaling me- 
• o ,-- o lecules. 
TPO concentration[nglml] 
4.  D iscuss ion  
Fig. 4. The TPO dose-response curves of FDC/P2 transformants ex- 
pressing Mpl mutants and parental FDC/P2 cells. Cells were cul- We demonstrated the functional domains of human Mpl for 
tured in the presence of various concentrations of TPO for 3 days. 
The number of viable cells was then measured by means of an MTS the tyrosine phosphorylation of cellular proteins, as well as 
colorimetric assay, proliferation and differentiation, using mouse IL-3-dependent 
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myeloid leukemia FDC/P2 transformants engineered to ex- parently unnecessary for proliferation and differentiation in 
press a series of truncated Mpl receptors. In the FDCP- our in vitro cell system. Stats do not appear to be involved 
Mp1635 transformant expressing a full-length Mpl, TPO in- in mitogenic responses to cytokines, as IFNs do not induced 
duce the tyrosine phosphorylation f several cellular signaling cell proliferation [31]. IL-6 [32], IL-2 [33] and IL-4 [34] mutant 
proteins, including Mpl itself and stimulated the proliferation receptors can trigger cell proliferation without the activation 
and expression of megakaryocyte/platelet-specific cell surface of Stat3, 5 and 6, respectively. Although biological functions 
antigens. These results indicated that the Mpl expressed in of Stat3 and 5 are not fully elucidated, our data indicated that 
FDC/P2 cells mediates ignals for TPO-triggered proliferation Stat3 and 5 are not directly involved in cell proliferation or 
and differentiation. Mutational analysis of Mpl further the inducible expression of megakaryocyte specific cell surface 
showed that two distinct regions of its cytoplasmic domain antigens including AP-51 and CD61. However, Stats regulate 
are involved in proliferation and differentiation signal trans- the expression of a wide range of genes induced by the activa- 
duction, tion of the receptors for cytokines uch as IFNs, IL-4 and IL- 
The Mp1558 receptor, including a region proximal to the 6 [18]. For example, Stat3 [35] is required for the IL-6-induced 
plasma membrane, mediated proliferative and differentiation expression of acute-phase r sponse genes, whereas Stat5 med- 
signals and induced the tyrosine phosphorylation of Jak2, iates the gene transcription of several milk proteins induced 
Tyk2, Vav and Mpl itself in the presence of TPO, indicating by prolactin [36]. Thus Stats play important roles for tran- 
that 45 membrane proximal amino acids are required for pro- scription of many genes induced by cytokines. Therefore, 
ducing both the proliferation and differentiation signals. This Star3 and 5 may mediate the TPO-induced transcription of 
region contained the boxl, but not box2 motif conserved in several proteins that are specifically expressed in megakaryo- 
other cytokine receptors uch as the erythropoietin and G- cyte-lineage cell type except AP-51 and CD61. 
CSF receptors and gpl30. This suggested that the region in- As described above, Vav is also tyrosine-phosphorylated by 
cluding the box2 motif in the Mpl cytoplasmic domain is not TPO stimulation in FDC/P2 transformants which Jak2 and 
essential for receptor-mediated cellular behavior, particularly Tyk2 were tyrosine-phosphorylated and proliferative re- 
proliferation. Several investigators have examined the signal sponses were seen. Vav are selectively expressed in hemato- 
transduction for cell proliferation mediated by mutants of poietic cells, and transiently tyrosine-phosphorylated in re- 
several cytokine receptors (reviewed in [17,18]). These studies sponse to stimulation of the cytokine, c-Kit tyrosine kinase 
revealed that the membrane proximal region of the cytokine and T-cell antigen receptors [37-41]. The Vav exogenously 
receptors is necessary and suffÉcient for cytokine-induced mi- expressed in fibroblast cells displays constitutive activation 
togenic signaling, and that boxl alone and in combination of the Ras-MAPK pathway [42]. Moreover, an activated ery- 
with box2 is required for binding of Jaks and for activation thropoietin receptor mutant constitutively associated with 
of the Jak-Stat pathway. Our findings that the box2 region is Jak2 and induced tyrosine phosphorylation of Vav [40], sug- 
not necessary for producing Mpl-mediated signals is not in gesting that Vav protein functions as a downstream signaling 
agreement with the data reported by Gurney et al. [8]. They molecule for Jaks. Thus Vav protein may be positioned be- 
showed that the Mpl cytoplasmic region within 63 amino tween Jaks and Ras. Our experiments showed that the tyro- 
acids, including the box2 motif, transmits proliferative signals sine phosphorylation f Vav in Mpl mutants positively corre- 
and activates Jak2, Statl and Stat3 whereas that within 42 lates with proliferative responses. In this study, however, we 
amino acids did not. This means that the 3 extra amino acids did not examine the phosphorylation and activation of pro- 
(aa 556 558) in Mpl are critical for producing proliferative teins directly involved in the Ras-MAPK signal transduction 
signals. These differences may be due to the cell line used. pathway. Further investigation is under way to elucidate the 
In this study, however, we found that the membrane-proximal role of Vav in Mpl-mediated signal transduction pathways. 
45 amino acid sufficient for producing proliferative signals Reports have described that the C-terminal region of sev- 
could not induce the tyrosine-phosphorylation of Stat3 and eral cytokine receptors plays an important role in transducing 
Stat5, and that tyrosine phosphorylation of these Stats re- differentiation signals with no effect upon cell growth [43-48]. 
quired the membrane proximal region containing 18 more Deleting this region from the G-CSF receptor [43-45] caused 
distal amino acids. We also showed that the tyrosine phos- phenotypic hanges in the cell surface antigens, a loss of gene 
phorylation of Stats induced by Mpl activation is not essential expression of neutrophil-specific enzymes, and the inhibition 
for proliferative signaling in our FDC/P2 system. FDCP- of morphological differentiation into neutrophils. In this 
Mp1558 cells exhibited lower proliferation rates and tyrosine study, we found that the C-terminal region (aa 595-635) of 
phosphorylation levels of Jak2, Tyk2, Vav and Mpl, although the Mpl, which is dispensable for proliferation, is also re- 
the expression level of the receptor was the same as or higher quired for producing differentiation signals that enhance the 
than those of other transformants. This suggested that the expression of megakaryocyte-specific ell surface antigens. On 
degree of phosphorylation of these signaling proteins directly the other hand, this C-terminal region was necessary for in- 
contributes to the proliferative response to TPO. Thus our ducing tyrosine phosphorylation f Shc. Thus the results sug- 
data suggested that Jak2, Tyk2 and Vav are involved in gested that the phosphorylation and activation of Shc is in- 
Mpl-mediated signal transduction for both proliferation and volved in the differentiation activity of the human Mpl 
differentiation, whereas Stat3 and Stat5 are not. Moreover, receptor. Little is known regarding the role of this Shc in 
the results also suggested that there are proliferative signal the differentiation of hematopoietic cells. The adaptor protein 
transduction pathways other than those of Jak-Stat involved Shc is tyrosine-phosphorylated during cytokine receptor acti- 
in Mpl-mediated signaling, vation, then it forms a complex with Grb2 and Sosl resulting 
The Mpl receptor activates Statl, 3 and 5 in various types in activation of the Ras-MAPK signal transduction pathway 
of cells [8,10,11,14]. However the role of Stats in signal trans- [49,50]. In fact, we confirmed that phosphorylated Shc binds 
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